Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L. Agostini, Mark R. Denison, Erica L. Andres et al.|mBio|2018Cited by 1.5k
Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L. Mackman, Tomáš Cihlář, Venice Du Pont et al.|Journal of Medicinal Chemistry|2021Cited by 90
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, Timothy P. Sheahan, David R. Martinez et al.|Science Translational Medicine|2022Cited by 83
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green MonkeysRichard L. Mackman, Tomáš Cihlář, Rao Kalla et al.|Journal of Medicinal Chemistry|2023Cited by 63
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infectionMeghan S. Vermillion, Danielle Porter, Eisuke Murakami et al.|Science Translational Medicine|2021Cited by 42